Introduction
Gastric cancer, one of the most lethal malignancies, is the fourth most common cancer and the second leading deadly cancer in the world. 1, 2 According to statistics of the National Central Cancer Registry of China, gastric cancer ranks second in both incidence and mortality of cancers in China. 3 Despite remarkable progress, the current treatments for gastric cancer are still not efficacious with overall 5-year survival rates <30%. 4 One of the main reasons for such a predicament might be that most patients were diagnosed at advanced stages of the disease. 5 Understanding the underlying mechanisms of gastric cancer initiation and progression may promote biomarker development for early detection of cancer.
Increasing evidence has proven that both environmental and genetic factors contribute to the occurrence and development of gastric cancer. 6 Helicobacter pylori infection is a well-established risk factor for gastric cancer, affecting >60% of all gastric cancer cases. 7, 8 However, not all the H. pylori-infected patients finally develop gastric cancer. Many other factors also play roles in gastric carcinogenesis, including micronutrient deficiencies, high body mass index, a high salt or a low fiber diet, over consumption of tobacco or alcohol, as well as genetic risk factors. [9] [10] [11] Increasing numbers of genetic variations have been found to influence susceptibility to gastric cancer in the previous epidemiological studies. 12, 13 The integrity and stability of the genome are primarily maintained by DNA repair systems, which include base excision repair, double strand break repair, mismatch repair, and nucleotide excision repair (NER). 14, 15 Among these systems, NER system plays a major role in monitoring and repairing DNA damages caused by exogenous and endogenous factors. 16 Defects in the NER system might threaten the integrity of genome and thus lead to the development of disease. 17 It is elucidated that reduced DNA repair capacity is most frequently associated with various human diseases including cancer. 18 NER process consists of four main steps: damage recognition, damage unwinding, damage incision, and new strand ligation. 19 There are at least eight key proteins (complementation groups XP-A to G and ERCC1) identified to limit the rate of NER process. 20 Specifically, XPA and XPC play critical roles in recognizing the DNA damage 21, 22 ; XPD and XPB are responsible for the process of damage unwinding 23, 24 ; ERCC1, XPF, and XPG are all essential components for the DNA damage incision. 25, 26 Thus far, several studies have been reported concerning the association between the polymorphisms in the NER pathway genes and the outcomes of gastric cancer. 27, 28 However, the association of these polymorphisms with gastric cancer risk was not fully elucidated. Therefore, the aim of this study was to further identify the association between these polymorphisms and gastric cancer susceptibility. In this study, we systematically analyzed the association between nine potential functional single nucleotide polymorphisms (SNPs) in the NER pathway genes (XPA, ERCC1, ERCC2, and ERCC4) and gastric cancer risk using 1142 patients and 1173 cancer-free controls in a southern Chinese population.
Materials and methods

Study population
This study was approved by the Institutional Review Board of Sun Yat-sen University Cancer Center, Guangzhou, Guangdong. The case group comprised 1142 patients with histologically confirmed gastric cancer enrolled from Sun Yat-sen University Cancer Center from February 2002 to September 2013. The control group consisted of 1173 healthy controls randomly recruited from the same region. 29, 30 Enrollment was restricted to unrelated ethnic Han Chinese population from South China. Detailed information was obtained on all subjects, including demographic characteristics (e.g., age and sex), and lifestyle habits (e.g., smoking habits and alcohol drinking). The classification criteria for smoking status and drinking status were described elsewhere. 31 Written informed consent was acquired from each participant, accompanying with a donation of 5 mL of venous blood sample.
Polymorphism selection and genotyping
The potentially functional polymorphisms of main genes in NER pathway were selected from dbSNP database (http:// www.ncbi.nlm.nih.gov/projects/SNP). Specifically, the following items were set as the selection criteria: 1) located at the 5′ untranslated regions (UTR), upstream promoter region, coding region, and 3′ UTR of genes; 2) the minor allele frequency was >5% in Chinese Han populations; 3) no obvious linkage between paired SNPs in linkage disequilibrium (R 2 <0.8). We also adopted SNPinfo (http://snpinfo.niehs.nih. gov/snpfunc.htm) to predict the potential functions of those polymorphisms; they could affect the activity of transcription factor binding sites or microRNA binding sites. As a result, the following polymorphisms were included: XPA (rs1800975 G>A, rs3176752 C>A); ERCC1 (rs2298881 C>A, rs11615 G>A, rs3212986 C>A); ERCC2 (rs3810366 C>G, rs238406 G>T, rs13181 T>G); and ERCC4 rs2276466 C>G.
DNA was extracted from the blood samples using QIAamp DNA Blood mini kit (QIAGEN Inc, Valencia, CA, USA). Genotyping were performed by the Taqman real-time PCR method on 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA), as previously described. [31] [32] [33] [34] For quality control purposes, four duplicate positive controls and four negative controls (without DNA) were used in each of 384-well plates. Moreover, 10% of the samples were randomly selected to re-genotype. There was 100% genotype concordance for each polymorphism among duplicates.
Statistical analysis
First, we adopted goodness-of-fit c 2 -test to check whether genotype frequencies of each polymorphism in controls were in Hardy-Weinberg equilibrium (HWE). Then the clinical and demographic characteristics were compared between cases and controls, using the two-sided c 2 -test. To investigate the association of the polymorphisms with gastric cancer risk, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Multivariate analysis using unconditional logistic regression model was performed to calculate adjusted ORs (AORs), with adjustment for age, sex, pack-years, smoking and drinking status. Genotype-based mRNA expressions were also conducted as we described previously. 31, 35 All statistical analyses were carried out using version 9.1 SAS software (SAS Institute, Cary, NC, USA). A two-sided P-value <0.05 was used as a criterion of significance. 
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Results
Population characteristics
This study consisted of 1142 cases of gastric cancer and 1173 healthy controls, whose individual characteristics are shown in Table S1 . With regard to sex, there was no statistically significant difference between cases and controls (65.59% male vs. 67.26% male, P=0.393). However, significant differences were observed between cases and controls, regarding age, smoking status, drinking status, and pack-years. Thereafter, these variables were further adjusted for in the subsequent multivariate analyses. Overall, 12.26% (140) We also performed a stratification analysis for the ERCC2 gene rs3810366 C>G and rs238406 G>T polymorphisms (Table 3 ). Both the rs3810366 (AOR=1.32, 95% CI=1.04-1.68) and rs238406 (AOR=1.32, 95% CI=1.03-1.69) polymorphisms conferred gastric cancer susceptibility in never drinkers.
Correlation analysis for ERCC1 mRNA expression levels and genotypes
We further conducted the ERCC1 genotype expression correlation analysis (Table S2) , aiming to explore underlying molecular mechanisms. The genotype data for 270 individuals were collected from HapMap. ERCC1 mRNA expression levels of lymphoblastoid cell lines from the same 270 individuals were extracted from SNPexp. We observed that 
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He et al genotypes of the rs2298881 C>A polymorphism were significantly correlated with decreased ERCC1 mRNA expression in Chinese subjects (P=0.003), Africans (P<0.0001), and combined subjects (P<0.0001). However, no genotype expression correlation was found for the rs3212986 C>A and rs11615 G>A polymorphisms in combined subjects.
Discussion
In the present hospital-based case-control study, we investigated the association between the polymorphisms in the NER genes and gastric cancer risk in a southern Chinese population. We observed a significantly increased gastric cancer risk associated with the ERCC1 rs2298881 A variant allele. However, we found that ERCC1 rs3212986 A variant allele was associated with decreased risk of gastric cancer. We also confirmed that the ERCC1 rs2298881 C>A polymorphism was associated with a decrease in ERCC1 mRNA expression. However, no association with gastric cancer risk was detected for the polymorphisms in the XPA, XPD, and XPF genes. To the best of our knowledge, this is by far the most comprehensive study investigating the association between the NER pathway genes and gastric cancer risk.
ERCC1 gene is located on chromosome 19q32.32, consisting of 10 exons and encoding a 297 amino acid protein. The ERCC1 protein is an indispensable component of the NER pathway. 37, 38 It interacts with XPA, XPF, and/or RPA, and catalyzes the 5′ cleavage of DNA lesions. 39 Given the critical role of ERCC1 protein in NER, it is biologically plausible that potentially functional ERCC1 gene variants could modify gastric cancer risk. Our findings are in accordance with others. For instance, He et al reported that ERCC1 rs11615 G>A was associated with an increased risk of breast cancer. 40 Likewise, the ERCC1 rs11615 G>A polymorphism was shown to increase the risk of developing lung cancer. 41 It is worth mentioning that we previously observed that ERCC1 rs11615A and rs2298881C variant alleles were associated with increased gastric cancer risk in an eastern Chinese population. 42 Moreover, patients with 2-3 ERCC1 risk genotypes had a significantly increased risk of gastric cancer compared with those with 0-1 ERCC1 risk genotypes. 42 However, the previous study did not detect an association between the rs3212986 polymorphism and gastric cancer risk. The discrepant results between the former study and the present study might be due to the different population selected. Our previous study population was recruited from East China, while the current study population was recruited from South China. Apart from our studies, two published studies regarding ERCC1 polymorphisms and gastric cancer risk were conducted in Italian population with relatively small sample sizes. 43, 44 One study included 314 cases and 548 controls, and the other included 126 cases and 144 controls. No significant association was detected in these two studies. However, all the included polymorphisms of ERCC1 in these two studies were not under investigation in the present study.
In the stratification analysis, our data suggested that the risk effect of ERCC1 rs2298881 CA/AA genotypes remained significant in males, never-smokers, pack-year of 0, packyears ≤30, never drinkers, non-cardia, stage I/II, and stage III/IV subgroups. The association between decreased gastric cancer risk and ERCC1 rs3212986 was more evident in subgroups of median age ≤58 years, males, never-drinkers, and non-cardia tumor. This phenomenon can be explained by the concept that susceptible individuals are likely to have a light exposure to risk factors. Young individuals, never smokers, or never drinkers are tended to be exposed to less environmental carcinogens. Thus, the role of genetic variants might not be outweighed by carcinogens in carcinogenesis in such subgroups. Considering the reduced sample sizes in the stratification analysis, some results might be just chance findings. Therefore, these results should be interpreted with caution. We further adopted the public data on ERCC1 genotypes and mRNA levels for the genotype-phenotype association analysis. A significant correlation between ERCC1 mRNA levels and rs2298881 C>A genotypes was observed, which provide further evidence that rs2298881 C>A may associate with gastric cancer by mRNA expression alteration, sequentially DNA repair capacity alteration. Therefore, additional larger case-control studies with functional analysis are warranted to explore the exact role of ERCC1 in gastric cancer risk.
We failed to detect any relationship between other polymorphisms and gastric cancer risk. Lack of an association of gastric cancer susceptibility with single NER pathway gene variants was also reported by other studies. For instance, in a case-control study including 246 cases and 1175 controls, no significant association was observed between the analyzed polymorphisms in the MSH2, MLH1, XRCC1, OGG1, and ERCC2 genes and gastric cancer risk. 45 However, some previous studies have demonstrated that some polymorphisms including rs11615 G>A were independent risk factors for gastric cancer. 42 Such a discrepancy among studies might be partly due to the limited sample sizes; small sample studies may not have sufficient statistical power to reveal an association. Another possible explanation was that the effect of each single variant was too weak to be detected. Moreover, the potential effect of polymorphisms in gastric cancer risk 
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Although we extensively analyzed a number of polymorphisms in the NER core pathway genes, some limitations still existed in this study. First, due to the nature of a retrospective study, selection bias and recall bias could not be completely avoided. To minimize such biases, we further performed multivariate logistic regression analysis on potential confounding factors such as age, smoking, and drinking status. Second, gastric cancer is a heterogeneous disease affected by multiple factors including H. pylori infection, environmental exposures, and diet habits, yet these data were not available for further analysis. Third, the sample size in the subgroup analysis was relatively small, which might limit the statistical power in the stratification analysis. Fourth, we adopted only the public data to preliminarily investigate the correlation between ERCC1 genotype and mRNA expression. The findings should be validated in gastric tissues in the future. We failed to quantify the ERCC1 mRNA levels in the target tissue of the included subjects due to tissue access constraints. Finally, as all participants were recruited from a hospital in South China, special caution should be paid in extrapolating the results to other populations.
In conclusion, we found that the ERCC1 gene rs2298881 C>A and rs3212986 C>A polymorphisms were associated with gastric cancer susceptibility in a southern Chinese population. Well-designed studies with larger sample sizes and functional analysis are required to further verify our findings.
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